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Normal transcription a d postranslational processing ofthe preprotaehykinin (PPT)-I gcne and regulated release of substance P and neurokinin 
A by the rat pancreatic endocrine cell-line, RINmSF, has been demonstrated, using radioimmunoassays (RIAs), reversed-phase (rp)HPLC and 
Northern blot analysis. This is the first stable cell-line found to express the PPT.I 8ene and provides an opportunity for investigating PPT-I gen¢ 
expression a d tachykinin biosynthesis. R INSmF cells are a model for the pancreatic beta.cell, which is not known to exhibit PFF-! gene xpression 
which may, therefore, be a feature of tile transformed state of these cells. These data may imply that ile taehykinins are important inpancreatic 
islet embryogenesis. 
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1. INTRODUCTION 
The PPT-I gene codes for the tachykinin peptide, 
substance P, which has been the most extensively stud- 
ied of neuropeptides and is involved in the regulation 
of many physiological processes [1]. However, sub- 
stance P is only part of the mammalian tachykinin sig- 
nal. Three other tachykinin peptides, neurokinin A and 
the neurokinin A-derived, neuropeptide K and neu- 
ropeptide c also arise from the PPT-I gene [2]. In addi- 
tion there is a second tachykinin gene, the PPT-II gene 
which codes for a single tachykinin, neurokinin B [3,4]. 
The PPT-I and PPT-II genes are differentially expressed 
and seem, therefore, to be under different regulatory 
control [5]. The biosynthesis of the PPT-I gene involves 
differential RNA splicing and differential precursor 
processing [6]. Pharmacological studies show that the 
tachykinin products of PPT-I sene expression have var- 
iable potencies and may interact in novel ways [7]. 
Therefore the differential biosynthesis of  these peptides 
will influence the nature of the tachykinin signal. The 
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availability of a stable cell line expressing the PPT-I 
gene should be valuable in studying factors regulating 
PPT-I gene expression and the mechanisms of  differen- 
tial biosynthetic processing. 
This paper reports that the rat insulinoma cell-line, 
RINmSF, [8] expresses the preprotachykinin (PPT)-I 
gene. This is the first report of a stable cell-line express- 
ing the PPT-I gene. The results indicate that the biosyn- 
thetic products of PPT-I gene expression in the 
RINmSF cell are similar to tho~e observed in examples 
of  normal tissues in Which the PPT-I gene is expressed. 
Theretbre this ceil-line should serve as a good model for 
further studies. Additionally, this study extends the bid. 
chemical characterisation f the R INm5F cell-line. This 
cell-line is a tumor cell-line which possesses many of  the 
differentiated characteristics of the pancreatic fl.eell for 
which it is a widely-used model [8]. Although the pan- 
creatic fl cell does not normally express the PPT-I gene 
our finding may relate to an ontogenetic characteristic 
of  the pancL-eatic fl cell. 
2. MATERIALS AND METHODS 
2.1. Materials 
Peptides were supplied by Peninsula Laboratories (St Helens, UK) 
and by Bachem Biochemiea GmbH (Heidetber 8, Germany). The PPT- 
C-flanking pcptide fra~nent used as RIA standard was supplied by 
Cambridge Research Bioehemieals (Cambridge, UK). HPLC solvents 
were obtained from Memk GmbH (Darmstaat, Germany). Chemicals 
for RNA extraction and analysis were obtained from Paesel and Lorei 
Gmblq (Frankfurt, Germany) and Fiuka Chemika-Bioehemika 
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GmbH (Neu-Ulm, Germany), 8-Bromo-cy¢lic adenosine mono- 
phosphate (8-Br-cAMP) and RNasin and Proteinase K were obtained 
from Boehrinser Mannheim Bioehemika OmbH (Mannheim, Ger- 
many), Bestatin and phosphoramidon were obtained from Serva 
OmbH (Heidelberg, Germany). The nylon transfer filters (Hybond 
N), BamHl cndonuclease and the Klenow fragment of DNA polym- 
erase 1 were obtained from Amersham-Buchlcr (B aunschweig, Ger- 
many). The XOMAT X-ray film was obtained from Eastman Kodak 
Co (ZuHch, Switzerland). Sep.pak cartridges containing oetadecylsil- 
ica (C-IS) were obtained from Waters Associates (Millford, USA). 
2.2. RINrnSF cell-line 
This cell line is derived from a radiation-induced insulin-producing 
rat tumor [8], which retains many of the differentiated functions of 
pancreatic ~ cells. The cells were grown in plastic Petri dishes under 
the conditions described by Praz and colleagues [9]. 
9_3. Be'traction of cells and tissue for analysis of peptides 
After decanting the culture medium cells were detached using a 
rubber policeman and extracted in boiling 1 M acetic acid, containing 
(}.2% dithiothreitol, for the subsequent measurement ofncurokinin A
and substance P. Cells were extract~ in boiling water for the subse- 
quent assay of the PFT C-flanking peptide. For quantitation of the 
cellular concentration a measured portion of each sample was taken 
before extraction for DNA measurement [10]. For comparison with 
normal rat tissues, simi!ar extracts ofrat small intestine were prepared 
as previously described [11]. Before RIA and HPLC analysis, samples 
were partially purified and concentrated using solid-phase extraction 
on SEP-PAK C-I fl cartridges as previousy described [11]. 
2.4. Radioimmunoassays ( RlAs ) 
Specific and sensitive RIAs for three ditTcrent end products of 
PPT.I biosynthesis, ubstance P(SP), neurokinin AfNKA) and the 
C-flanking peptides of PPT (CPPT), were performed as described 
previously. The SP RIA antiserum(rabbit), SP3, is specific for SP 
showin~ no cross-reaction with any other mammalian peptide includ- 
ing NKA, neurokinin B(I'qKB) and C-PPT [12]. The NKA RIA antis- 
erum (rabbit), 0~4, exhibited, in RIA, the following variable 
crossrcaetivity with the NKA-related peptides; NKB (30%), neu- 
ropeptides K (100%) and &gamma; (160%), and no cross-reaction 
with SP and C-PPT [13]. The C-PPT RIA employed the antiserum 
(guinea pig), GP4, which fully cross-reacts with the isolated human 
and rat PPT C-flanking peptides and exhibits no cross.reaction with 
tide tachykinin peptides [11]. 
2.5. High.pressure liquid chromatography 
The rpHPLC analysis was perfocrned as previously described [13]. 
F.ach of the partially purified cell tissue extracts was injected onto a 
125×4 mm LiChro CART column of C-18 LiChrospher (100-RP-18,5 
,am), preequilibrated with 50 mM potassium phospt)ate buffer, pH 2.5. 
The column was calibrated with standard synthetic peptides as previ- 
ously described. After rumple injection the columu was elrated with a 
linear gradient of solvent B (acetonitril~water (70:30) containing po- 
tassium phosphate buffer, final concentration 37 raM, pH 2.5). The 
gradient conditions used are indicated in Fig. 1. Each of the fractions 
was evaporated and, following addition of 1 ml water, and then as- 
sayed at dilution by RIA. 
2.6. Release studies 
These experiments were carried out using plated cells according to 
the procedure des~rlbed by .lens and collcague.s [14] with certain mod- 
ifications. The peptidas© inhibitors phosphoramldon (4x10 "~ M) and 
bestatin (lf) "a M) were always included in the incubation buffer which 
was Kr~bs-Ringer bicarbonate buffer containing 9.07% bovine serum 
albumin and 10 raM HEPES buffer, pH 7.4. The incubation buffer 
was colh.*cted before and after 15 rain incubation with either 50 mM 
potassium chloride (replacing the equivalent amount of sodlum chlo- 
ride) or 8-Br-eAMP (2 raM), Befo~'e RIA the samples of collected 
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medium were concentrated bysolid phase extraction using Scp-pak 
(C-18) cartridges as for the tissue extractions. 
2.7. RNA extraction and tVorthem blatttng 
Total RNA was extracted from cultured ceils and from frozen tissue 
samples using a procedure based on a protocol by Cathala nd col- 
leagues [15]. Tile followinB rat tissues were selected as control tissues 
for the RNA analysis; corpus triatum and trigeminal ganglia which 
are known to be rich sources of FPT-I mRNA [5] and cerebral cortex 
(without olfactory lol~s) and liver which appear devoid of PPT-I 
mRNA. The brain dissections were performed according to Glowinski 
and Ivcrsoa [16]. Lysis of botk '.'el.! ~ . and tissue was achieved by addi- 
tion of 5 M suanidinium isothioeyanato containing 50 mM Tris-HCl 
buffer, pH 7.5, I0 mM EDTA and 8% fl-mercaptoethanol. Tissue 
samples wore then homogenized (Ultra Turrax). Nucleic acids were 
precipitated at 4"C overnight in the presence of 7 vols. 4 M LiCI. 
Following sedimentation by centrifugation (10,000xg) the samples 
were washgl with 3 M LiCl, rcsedimented by centrifugation a d resus- 
pcnded in 10 mM Tris-HCl pH 7.4, 5 mM EDTA, 1% SDS and 100 
,ttg/ml Proteinas¢ K. Following 1 hour incubation at 42'C, the reaction 
was terminated by phenol/chloroform extraction and the aqueous 
phase precipitated by addition of 1/10 vol. 3 M sodium acetate pH 5.2 
and 2.5 vol. 100% ethanol. The precipitates were collected by ¢entrif- 
ugation, resuspanded in 20 mM Tris-HCl buffer, pH 7,4, 60 mM 
NaCI, 7 mM MgClz, I mM dithiothreitol, 250 U/ml RNasin, 100 U/ml 
DNas¢ and incubated at 37°C for 30 rain. The reaction mixture was 
extracted twice with phenol/chloroform and the final aqueous phase 
precipitated with ethanol. Following recentrifugation, the pellet was 
resnspended in 75% ethanol and again centrifuged. The final RNA 
pellet was dissolved in diethylpyrocarbonate treated water and stored 
at -30°C before farther analysis. 
Electrophoresis of the RNA samples was performed using a 1.2% 
agarose gel containing 2.2 M formaldehyde. The RNA was then trans- 
ferred to nylon filters (Hybond N) (overnight capillary blot) using 3.6 
M NaCI, 0.2 M sodium phosphate, pH 7.7, 20 mM EDTA. Following 
baking, the membrane was stained in 0.5 M sodium acetate pH 5.2 
containing 0.05% Methylene blue which allowed identificatioa f the 
positions of 285 and ISS rRNA. The membranes were prehybridized 
for 3 h in 50% fonnamide, 5xSSC (0.75 M NaCI, 0.075 M sodium 
citrate), 5×Denhardt's (0.1% each of ficoll, polyvinylpyrrolidone and 
bovine serum albumin (fraction V)), 1/ag//.tl sonicated salmon sperm 
DNA. The filter was hybridized Overnight with the ~:P.labelled PPT-I 
eDNA (see section 2.8) contained in prehybridization solution con- 
taining only l×Denhardt's, Prehybridization a d hybridization tem- 
perature was 42°C. The blot was Washed in 2×$SC at room tempera- 
tare, for 15 min in 2×SSC containing 1% sodium dodecylsulphate  
42°C, for 10 rain in 0.1×$SC at room temperature and Ibr 15 rain in 
0.1×SSC at 42*C. The washed filter was exposed to X-ray film 
(XOMAT) at -80°C in the presence of an intensifying screen. 
2.8. Radiolabelling of PPT-I eDNA 
The/~-PPT eDNA insert (containing exerts !-6 and 90 naeizotides 
of cxon 7 of the PPT 1 aerie) was excised from the plasmid pO 1,8.PPT 
[17] (a sift from Dr. J.E. Krause) using restriction endonuclease 
BamHl, 50 ng,@.PPT and incubated with Klenow fragment of DNA- 
polymerase 1 in the presence of random sequence hezanucleotides, 
[~-3aP]dCTP (Amersham-Buchler, Germany) and the three other, un- 
labeled eoxyribonucleotidcs. Unincorporated naelectides were re. 
moved by gel filtration, The specific activity of the ,~.PPT probe: 
:~-I0×106 cprn/10 pl (10 ng). 
3. RESULTS AND DISCUSSION 
Similar concentrations of tachykinin ~uv~Lan~;o'" '- . . . .  P 
and neurokinin A)-immunorcactivitios were measured 
in R INm5F cell acidic extr~tcts (Table I). Concentra. 
tions are expressed in terms of' micrograms cell DNA.  
Volume 312, number 2,3 FEBS LETTERS November 1992 
NKA- IR 
In~31ml) 
10- 
e,. 
e.. 
4-  
Z- 
C~ 
CPPT-  Ifl 
(ngtrnl) 
6-  
4 -  
NEUROKININ A 
, - -  . . ,  
I ! • .5 
p~ 
I 
! 
I~.~ Imtn) 
% ACN 
40 
-~o 
-20 
-'/O 
PPT-C-F lank ln9  Poptido 
, . , , "  
I ' "  
I 
I 
I 
, d ~b =b ' ' ' - - '  
~O 40 §0 I~0 70 
tired (mini 
% A~N 
49 
-an  
-~o 
=1o 
-0  
UKA - m NEUROKININ A 
Ing/mll 
4 
~-  ! ! V, . l  I 
* - + - - ,  • , i l - - i  
O 19 20 30 40 00 O0 70 110 
llmo (mini 
CPPT - Ifl 
(niltml) PPT-  e - FP, fikln8 PIIl~i~hl 
4 
f " / " I  
'" / I 
o / I l l  . i  
im~ tmm~ 
"l, +~,II 
"li 
0 
ACI4 
4O 
-an  
-20  
. 
"~P - IR 
[ngtml) 
6 
2 -  
SUBSTANCE P 
t 
/ 
i 
I I [n0  | f r i l l  
J J J 
SO 00 70 
SP - in 
%/ken (nS/ml) 
40 4. 
-80  3, 
• 20 2, 
i 
-10 1- 
SUBSTANCE P 
[RIN CELL Mldlm~ ] ~ , . s  
] 
I 
I 
a 0 _ . L .  • _ J 
8 1'o io~'o 4b ~b 6'o ¢o 
t ime I m~l )
% AgN 
"40 
"a0 
• 10 
Fig, 1, HPLC fractionation of SP-, NKA-, PPT-l.C-flanking peptide-lRs extracted from RINmSF cells, from rat small intestine (data for SP-IR 
not shown) and from an extract of medium (containing 50 mM KCI) collected following incubatio, with RINmSF cells (data for SP-IR only shown). 
The dashed line in 20eh profile indicates the gradient of acetonitrile (ACN) with which the column was eluted. The ar rows  in the NKA.IR profiles 
indicate the elution times, under these conditions, of the following synthetic peptides: neuropeptide gamma; (1), neurokinin A(4--10). ncuropeptide 
K (4) and neurokinin B (5). The arrow in the SP-IR profiles indicates the elation time, under thes~ conditions, of synthetic sub~tance P. 
Similarly expressed concentrations of  the PPT C-flank- 
ing peptide measured in RINmSF cell water extracts are 
also shown and are of the same magnitude as the 
tachykinin concentrations. The similar molar concen- 
trations o£ substance P- and the PPT-C-flanking pep- 
tide-IRs have also been measured in extracts of normal 
rat tissue [11]. The concentration of  NKA-IR relative 
to these other PPT-I-derived immunoreaetiviti~ ap- 
pears, normally, to be tissue-dependent presumably be- 
cause of  tissue-variable xpression of the alpha form of 
PPT [2] which does not contain the transcript of the 
NKA-encoding, exon 6 of the PPT-I gene. Since the 
~-r.ounts of all three PPT-l-derived peptides measured 
in the RIN cell extracts are not significantly different, 
the RINmSF cells appear to express little of 0t-PPT. 
The rpHPLC analysis reveals that RINmSF cells con- 
tain similar molecular forms o£ NKA-, SP- and PPT-C- 
flanking immunoreaetivities as in rat intestine (Fig. 1), 
however with some interesting differences. SP-IR elutes, 
in each case, as a single peak with an vlution time iden- 
tical to the synthetic standard peptide (data For small 
Table ! 
Concentrations (pmol/mg DNA) of substance P-IR (SP), neurokinin 
A-IR (NKA) and the PPT-I-C flanking peptide-IR (C-PFr) in 
RINm5F cells. Values expresm.~d m~ans ± $.E.M. n = numl~r of 
extraction samples. 
$P NKA C-PFF 
(, = 9) (n = 9) (n = 5) 
33.9 +- 3.7 30.8 ± 5.0 28.9 ± 4.7 
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Fig. 2. A Northern blot of total RNA extracted from the trigeminal 
ganglion (5/~g), corpus striatum (striatum) (3.5/~g), cerebral cortex 
(cortex) (6 gg), and liver (10 #g) of rat, and from RINmSF cells (12, 
6 and 3 pg). 
intestine not shown). NKA-IR elutes, in each case, as 
one major peak with an elution time corresponding to 
that of the NKA standard. However in extracts of rat 
intestine a significant amount of NKA-IR elutes at a 
position corresponding toneurokinin A (4-10) and this 
is not detected on analysis of RIN cell extracts. Also no 
significant NKA-1R extracted from the RIN cell elates 
with the elution times of neuropeptides K and y. The 
PPT C-flanking-IR from the RIN cell eludes as a single 
major peak unlike PPT C-flanking-IR from the rat 
small intestine which, as previously shown [11], resolves 
on rpHPLC as two major peaks. The second of these 
two intestinal PPT-I C-flanking-immunoreactive peaks 
has an elution time (31 min) identical to that of the 
Table II 
Concentrations (pmol/ml) of SP-IR (SP) and NKA-IR (NKA) meas- 
ured in control and 'stimulation' media collected following incubation 
with plated R1NmSF cells. See text for contents of control medium. 
The 'stimulation' media consisted of control medium containing either 
~0 mM KCI (included in place of the equivalent amount of NaCI of 
the control medium) (in Ex~riment 1) or 2 mM 8-Br-cAMP (Exper- 
iment 2). Values ~hown as mean + S.D. 
SP NKA 
Experiment 1
Control (n=5) 201 + 56 582 ± 110 
50 mM KCI (n=9) 994 ± 461 1,571 ± 554 
Experiment 2
Control (n=2) 143 ± 16 130_ 22 
2 mM 8-Br-cAMP (t.~=2) 408 __. 56 420 + 35 
single major RIN cell PPT-I C-flanking-IR peak and 
has been previously charaeterised as corresponding to 
the rat homologue of the structurally characterised bo- 
vine PPT-I C-flanking peptide [11]. 
The combined rpHPLC and RIA analysis indicates 
that the post-translational processing of the PPT I gene 
is similar to what occurs in an example of a normal rat 
tissue which expresses the PPT-I gene. However the 
data also indicates that some interesting detailed iffer- 
ences do exist between the RIN cell and rat intestine in 
the pattern of post-translational processing of PPT-I 
and these require further investigations. Furthermore, 
Northern blot analysis indicates that the RINmSF cell 
appears to transcribe the PPT-I gene in a similar man- 
ner to normal rat tissue. Fig. 2 shows the results of the 
analysis of similar amounts of total RNA extracted 
from RINm5F cells and the corpus striatum, cerebral 
cortex, trigeminal ganglion and liver of the rat. With 
RNA from the RIN cell, corpus striatum and trigeminal 
ganglion, a single hybridisation signal of identical mo- 
bility was detected with the S'-P-labelled fl-PPT eDNA, 
whereas no signal was detected with cerebral cortex [5] 
and liver RNA, which are tissues known not to express 
the PPT-I gene. The position of the/~-PPT hybridisation 
signal in relation to the ribosomal RNA bands (revealed 
following total RNA staining with Bromophenol blue) 
corresponds approximately to the predicted position of 
PPT mRNAs [6]. 
The regulated release of tachykinins from RINm5F 
cells was determined b2/ RIA of extracted incubation 
buffer before and following the inc!usion of raised pot- 
tasium concentrations (50 raM) or 8-Br-cAMP. An in- 
crease of both $P-IR and NKA-IR was detected in the 
incubation butter in the presence of raised pottasium 
and 8-Br-eAMP (Table II) compared to samples of con- 
trol media collected immediately prior to exposure to 
the test reagent. Therefore membrane depolarisation by 
raised extracellular potassium and stimulation of the 
regulated secretory pathway with 8-Br-cAMP causes 
tachykinin release from RINmSF cells. In Fig. 1 the 
result of rpHPLC of SP-IR in medium collected follow- 
ing stimulation with elevated pottasium concentrations 
is shown and reveals a single peak of Ig  corresponding 
to authentic substance P. 
This study presents the RINmSF cell line as a model 
for the investigation of PPT-I gene expression and the 
mechanisms of post-translational processing and regu- 
lated release of the tachykinins. The results of this study 
also extend the biochemical eharaeterisation of the 
R1Nm5F cell-line which is a well-used model for the 
pancreatic fl cell. The expression of the PPT-I gene by 
the RINmSF cell appears to involve normal endocrine 
biosynthetic processes and regulated secretion of the 
taClAyAxhAl.S and is ,u,,,e~ ,~,,,~,,.~ o, . , e  d i~Ae. tmteu  
state of this cell-line. The RINm5F cell-line also syn- 
thesises somatostatin [8] in addition to insulin, and 
other pancreatic islet tumor cells also exhibit pluripo- 
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tential for islet peptide hormone synthesis [18,19]. It is 
suggested that such tumors cells represent a stage in islet 
embryoge~iesis [18], which appears to involve a pluripo- 
tentiaI progenitor cell [20]. Although the pancreatic 
beta; cell appears normally not to express the PPT-I 
gene, it is possible, that the PPT-I gene is transiently 
expressed uring embryogenesis of the p cell. There are 
examples of  neuroendocrine genes being transiently 
'switched on' during development [21-23] or under spe- 
cific physiological conditions [23,24]. Such physiologi- 
cal phenotypic plasticity is often revealed in the neoplas- 
tic state [25]. The tyrosine hydroxylase gene, which is 
normally considered a marker for catecholaminergic 
cells is expressed by pancreatic ,8 cells when they un- 
dergo physiologically-induced hyperplasia and also 
during islet cell embryogenesis [23]. Furthermore, em- 
bryological studies have indicated that precursor cells 
of pancreatic islet cells are phenotypically similar to 
those ofeateeholaminergic cells [20]. Interestingly, sym- 
pathetic catecholaminergic cells have been shown to 
express the PPT-I gene [24]. 
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